BOSTON and FISHERS, Ind., June 13, 2023 /PRNewswire/ — Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO), today announced the appointment of Susan D’Costa, Ph.D. as Chief Technology Officer (CTO) and Nicole O’Brien, Ph.D. as Chief Commercial…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.